Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-14 Huizenga Theodore Alan SVP, Chief Accounting Officer Sale −140 $81.14 $11K 14,072
2021-10-14 Kassberg Thomas Richard CBO & EVP Sale −286 $81.14 $23K 216,266
2021-10-14 Parschauer Karah Herdman EVP and General Counsel Sale −310 $81.14 $25K 28,358
2021-10-14 KAKKIS EMIL D President & CEO Shares withheld for taxes −853 $81.00 $69K 594,347
2021-10-14 Pinion John Richard See Remarks Sale −358 $81.14 $29K 49,764
2021-10-14 Dier Mardi CFO & Executive Vice President Sale −3,261 $81.16 $265K 38,762
2021-10-12 Dier Mardi CFO & Executive Vice President Sale −3,477 $82.79 $288K 42,023
2021-09-30 Kassberg Thomas Richard CBO & EVP Option exercise +109,734 $0.31 $34K 216,552
2021-09-30 Kassberg Thomas Richard CBO & EVP Option exercise · Stock Option (Right to Buy) −109,734 0
2021-09-13 Huizenga Theodore Alan SVP, Chief Accounting Officer Gift −819 14,212
2021-09-08 Parschauer Karah Herdman EVP and General Counsel Option exercise +7,336 $54.50 $400K 36,004
2021-09-08 Parschauer Karah Herdman EVP and General Counsel Sale −7,336 $100.65 $738K 28,668
2021-09-08 Parschauer Karah Herdman EVP and General Counsel Option exercise · Stock Option (Right to Buy) −7,336 17,664
2021-09-02 Bedrosian Camille L EVP and Chief Medical Officer Option exercise +2,500 $55.00 $138K 41,275
2021-09-02 Bedrosian Camille L EVP and Chief Medical Officer Sale −2,500 $100.18 $250K 38,775
2021-09-02 Bedrosian Camille L EVP and Chief Medical Officer Option exercise · Stock Option (Right to Buy) −2,500 53,000
2021-09-01 Bedrosian Camille L EVP and Chief Medical Officer Option exercise +2,500 $55.00 $138K 41,275
2021-09-01 Bedrosian Camille L EVP and Chief Medical Officer Sale −2,500 $100.03 $250K 38,775
2021-09-01 Bedrosian Camille L EVP and Chief Medical Officer Option exercise · Stock Option (Right to Buy) −2,500 55,500
2021-07-06 Harris Erik EVP & Chief Commercial Officer Sale −375 $91.53 $34K 25,333

Page 18 of 21 · 410 trades